Literature DB >> 26811468

Profile of Lawrence Steinman.

Tinsley Davis.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26811468      PMCID： PMC4760808          DOI： 10.1073/pnas.1600083113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

2.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

Authors:  T A Yednock; C Cannon; L C Fritz; F Sanchez-Madrid; L Steinman; N Karin
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

3.  Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial.

Authors:  B W van Oosten; M Lai; S Hodgkinson; F Barkhof; D H Miller; I F Moseley; A J Thompson; P Rudge; A McDougall; J G McLeod; H J Adèr; C H Polman
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

4.  Therapy of autoimmune diseases with antibody to immune response gene products or to T-cell surface markers.

Authors:  L Steinman; M K Waldor; S S Zamvil; M Lim; L Herzenberg; L Herzenberg; H O McDevitt; D Mitchell; S Sriram
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.

Authors:  L Steinman; I R Cohen; D Teitelbaum; R Arnon
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

6.  Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.

Authors:  Michael Phillip Kurnellas; Eliver Eid Bou Ghosn; Jill M Schartner; Jeanette Baker; Jesse J Rothbard; Robert S Negrin; Leonore A Herzenberg; C Garrison Fathman; Lawrence Steinman; Jonathan B Rothbard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

7.  Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.

Authors:  Peggy P Ho; Jennifer L Kanter; Amanda M Johnson; Hrishikesh K Srinagesh; Eun-Ju Chang; Timothy M Purdy; Keith van Haren; William R Wikoff; Tobias Kind; Mohsen Khademi; Laura Y Matloff; Sirisha Narayana; Eun Mi Hur; Tamsin M Lindstrom; Zhigang He; Oliver Fiehn; Tomas Olsson; Xianlin Han; May H Han; Lawrence Steinman; William H Robinson
Journal:  Sci Transl Med       Date:  2012-06-06       Impact factor: 17.956

8.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Authors:  May H Han; Sun-Il Hwang; Dolly B Roy; Deborah H Lundgren; Jordan V Price; Shalina S Ousman; Guy Haskin Fernald; Bruce Gerlitz; William H Robinson; Sergio E Baranzini; Brian W Grinnell; Cedric S Raine; Raymond A Sobel; David K Han; Lawrence Steinman
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

9.  Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis.

Authors:  J W Lindsey; S Hodgkinson; R Mehta; R C Siegel; D J Mitchell; M Lim; C Piercy; T Tram; L Dorfman; D Enzmann
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

10.  Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis.

Authors:  Jacqueline L Grant; Eliver Eid Bou Ghosn; Robert C Axtell; Katja Herges; Hedwich F Kuipers; Nathan S Woodling; Katrin Andreasson; Leonard A Herzenberg; Leonore A Herzenberg; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2012-08-01       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.